Evidence mapPaperPMID 39399748Full record

ArticleInfectious diseases & clinical microbiology2024

Antimicrobial Use Among Outpatients at Benjamin Mkapa Hospital in Dodoma Central Zone of Tanzania: A Prospective Descriptive Study.

Kauke Bakari Zimbwe, Yusto Julius Yona, Charity Alphonce Chiwambo, Devis Antony Mhagama, Alphonce Bilola Chandika, Humphrey Sawira Kiwelu, Reuben Sunzu Mkala, Omary Salim Kizenga, Mfaume Michael Mleke, Moshi Moshi Shabani

Abstract read
In one paragraph

Article in Infectious diseases & clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kauke Bakari ZimbweOncology and Bone Marrow Transplant Pharmacy Unit, Pharmacy and Compounding Section, The Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0003-4833-8142
Yusto Julius YonaOncology and Bone Marrow Transplant Pharmacy Unit, Pharmacy and Compounding Section, The Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0009-0007-3741-031X
Charity Alphonce ChiwamboThe Aga Khan Hospital Trust, Dar es Salaam, United Republic of Tanzania.ORCID https://orcid.org/0009-0006-8898-8923
Devis Antony MhagamaDepartment of Pharmacy, Dodoma Christian Medical Centre Trust, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0009-0007-0363-3435
Alphonce Bilola ChandikaHospital Executive Committee, The Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0009-0003-6158-3043
Humphrey Sawira KiweluDirectorate of Clinical Support, The Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0001-6274-699X
Reuben Sunzu MkalaDiagnostic Services, Ministry of Health, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0000-0002-4301-2111
Omary Salim KizengaTanzania Medicines and Medical Devices Authority, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0009-0009-7263-5017
Mfaume Michael MlekeOncology and Bone Marrow Transplant Pharmacy Unit, Pharmacy and Compounding Section, The Benjamin Mkapa Hospital, Dodoma, United Republic of Tanzania.ORCID https://orcid.org/0009-0005-6772-4956
Moshi Moshi ShabaniDepartment of Biomedical Research and Clinical Trials, Ifakara Health Institute, Bagomoyo, United Republic of Tanzania.ORCID https://orcid.org/0000-0002-6871-8751

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Irrational antimicrobial use (AMU) has led to an exponential increase in antimicrobial resistance (AMR) in hospitals and communities, which creates challenges in treating infectious diseases caused by bacteria. This study aimed to evaluate antimicrobial prescriptions and usage patterns for treating bacterial infections among outpatients at Benjamin Mkapa Hospital (BMH). Materials and Methods: A prospective descriptive study design was used to evaluate the AMU trend. The data were collected from August 2022 to October 2022 from outpatient pharmacies at BMH using the World Health Organization/International Network of Rational Use of Drugs (WHO/INRUD) indicators. The simple random sampling method was employed to select the prescriptions. The WHO AWaRe (Access, Watch, and Reserve) classification was used to classify common antimicrobials. We analyzed the prevalence of outpatient AMU, including the types of antimicrobials, indications, and compliance with treatment guidelines. We also examined the number of antimicrobials per prescription and the adherence to drug use. Results: We examined 1557 prescriptions, 406 (26.1%) (WHO recommendation 20.0-26.8%) of which included antimicrobials. All prescriptions with antimicrobials were written in generic names, drug utilization-90% (DU90%) was 100% (WHO recommendation 100%). The number of parenteral antimicrobials prescribed was 79 (19.5%) (WHO recommendation 13.4-24.1%). Furthermore, prescriptions with antimicrobials that complied with the current Standard Treatment Guidelines and National Essential Medicine List in Tanzania (STG/NEMLIT) were 369 (90.9%) (WHO recommendation 100%). Most antimicrobials were prescribed as monotherapy, accounting for 265 (65.3%). There were 1.4 (WHO recommendation 1.6-1.8) antimicrobials per prescription. Our study identified 21 commonly prescribed antimicrobials, whereby 9 (42.9%) (WHO recommendation >60%) antimicrobials were Access, 10 (47.6%) (WHO recommendation <20%) Watch, and 2 (9.5%) (WHO recommendation <1%) Reserved classes. Conclusion: Our study showed that BMH has optimal practices for prescribing and using antimicrobials for outpatients. It further underlined the need to expand and strengthen antimicrobial stewardship efforts to reinforce prescribing antimicrobials.

Indexed as

antimicrobial resistanceantimicrobialsantimicrobial stewardshipantimicrobial useAWaRE classificationWHO/INRUD indicators

Identifiers

PMID39399748
PMCPMC11465431

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.